A Novel Anti-CD19 Chimeric Antigen Receptor T Cell Product Targeting a Membrane-Proximal Domain of CD19
Ruchi P. Patel(University of Pennsylvania), Marco Ruella(Parker Institute for Cancer Immunotherapy), Gae-Baik Kim, Soohwan Kim(Dong-A University), Min Yoon, Jong Seo Lee(University of Toronto), Puneeth Guruprasad(Parker Institute for Cancer Immunotherapy), LeiGuang Cui, Junho Chung(Cancer Research Institute), Youngha Lee(University of Pennsylvania), Soohyun Kim(Korea Basic Science Institute), Jongho Lee(Seoul National University), Sung‐Min Kim(Dong-A University), Ki Hyun Kim(Chonnam National University Hwasun Hospital), Ji‐Ho Park(Korea Advanced Institute of Science and Technology), Hyun‐Jong Lee, Ji-Hyeon Choi, Yong Gu Lee(Parker Institute for Cancer Immunotherapy), In-Sik Hwang, Guewha Lee
Cited by 0
Related Papers
GABA-modulating bacteria of the human gut microbiota
|Nature Microbiology|2018|1.1k
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
|Journal of Clinical Investigation|2016|554
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast
|Proceedings of the National Academy of Sciences|2010|433